CIBC Private Wealth Group
DARE icon

CIBC Private Wealth Group’s Dare Bioscience DARE Stock Holding History

CIBC Private Wealth Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,083
Closed -$25K – 873
2022
Q3 		$25K Hold
2,083
– – ﹤0.01% 896
2022
Q2 		$31K Hold
2,083
– – ﹤0.01% 988
2022
Q1 		$37K Hold
2,083
– – ﹤0.01% 1060
2021
Q4 		$50K Hold
2,083
– – ﹤0.01% 999
2021
Q3 		$42K Hold
2,083
– – ﹤0.01% 922
2021
Q2 		$47K Hold
2,083
– – ﹤0.01% 1019
2021
Q1 		$42K Buy
+2,083
New +$50.8K ﹤0.01% 1019

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

CIBC Private Wealth Group's DARE Position: Q4 2022 in Review

CIBC Private Wealth Group sold out of Dare Bioscience (DARE) in Q4 2022, closing a stake of 2,083 shares — an estimated $25K sold.

CIBC Private Wealth Group first reported a position in DARE in Q1 2021 and held it in 7 quarters. The position peaked at $50K in Q4 2021. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2022.

  • CIBC Private Wealth Group reported no remaining Dare Bioscience position as of Q4 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 2,083 Dare Bioscience shares in Q4 2022, an estimated $25K.
  • CIBC Private Wealth Group first reported a position in Dare Bioscience in Q1 2021 and held it in 7 quarters.
  • CIBC Private Wealth Group's Dare Bioscience position peaked at $50K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2022.

Based on CIBC Private Wealth Group's 13F filing for Q4 2022, filed 13 Feb 2023.